
|Articles|July 12, 2013
Supplements and Featured Publications
- The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Pa
- Volume 19
- Issue 10 Suppl
Post Test: The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Patient Management and Outcomes
Advertisement
Instructions
After reading “The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Patient Management and Outcomes,” complete the program evaluation and select the single best answer to each of the posttest questions.
A statement of continuing education credit will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher on the posttest.
Articles in this issue
about 13 years ago
Optimizing Therapy and Management of Neurogenic Bladderabout 13 years ago
The Epidemiology and Pathophysiology of Neurogenic BladderAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
5 August FDA Approvals Marked by Novelty, Pushback
4
60% of US Women Face Barriers to Postpartum, Mental Health Care
5





